AP Domain Minutes 13November2012: Difference between revisions
Jump to navigation
Jump to search
Created page with "==DRAFT== ==Attending== Colin Murphy [mailto:colin.murphy@mtutive.com colin.murphy@mtutive.com]; Mary Kennedy [mailto:mkenned@cap.org mkenned@cap.org]; Mike Henderson [mailto:mi..." |
|||
| (6 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
==Attending== | ==Attending== | ||
'''Mary Kennedy [mailto:mkenned@cap.org mkenned@cap.org]; Hugh Glover hugh_glover@bluewaveinformatics.co.uk ; Raj Dash r.dash@duke.edu ; Francois Macary francois.macary@gmail.com ; Harry Solomon harry.solomon@ge.com ; Alessandro Sulis asulis@crs4.it ; Dave Toomey david.toomey@leica-microsystems.com ; John Murphy [mailto:john.murphy@mtuitive.com john.murphy@mtuitive.com] | |||
==MINUTES== | |||
# '''Agenda Review''' | |||
# '''IHE AP Report''' | |||
## The report will be sent to Chris to put on domain once it is completed. | |||
## Vendors have not implemented yet in France….. very few vendors in the French market for anatomic pathology | |||
##There are some in Spain. | |||
##French vendors will have to implement. APFR will be required. | |||
##There is a national project of care coordination around cancer cases which is driven by ___ organization and the National Cancer institute in France. | |||
##Presently working on the Tumor Board Report. | |||
##Implementation should begin in 2013. | |||
##…………..is working to update the implementation guide with 10 additional ……………so that the guide follows the medical specification of National ……………Institute. | |||
# '''Status of IHE–IPALM Joint Initiative (Encoding Breast Cancer APSR)''' | |||
##''The feedback from the face-to-face meeting in Stockholm is scheduled to occur this Friday, November 16, 2012 at 8:00AM in the teleconference for ICD11.'' | |||
##Comments on staging will be discussed. | |||
##Raj will be able to provide feedback after this Friday. | |||
##Email questions and concerns to Raj and he will share will submit for group discussion on Friday. | |||
##A concern about the rational of not taking all the details of the T&M was voiced. Is it mainly for intellectual property issues or for simplification? | |||
##There is opportunity in a single code to capture some epidemiologic data. It would be very difficult to capture all the T&M details in a single code with the code space that is available to ICD11. It is possible with the second code to provide more granular information. | |||
##Mary will post to IHE AP site all the documents sent by Raj summarizing where ICD11 is going. | |||
##A question was posed about whether there is a terms of reference document for ICD11. What is considered within the scope of what they are trying to do in ICD11? | |||
##Raj will get the document and share. He will also find out if IHE can have access to draft of ICD11 to provide comments. | |||
##IPALM next step: submit questions to INI Chair. | |||
##Mary will put together questions for INI and post IPALM presentation on IHE. | |||
# '''''''''Status of ICCR ''' | |||
##Will work on nephrology/urology/pathology | |||
##Have contact with Spain, Italy, France, Switzerland, and New Zealand | |||
##Have connection with….UICC | |||
##It is not clear how IHE can be involved. | |||
##There is no discussion regarding any kind of technology implementation of this at this point – IHE may bring to group. | |||
##Mary will find out more information - regarding discrepancy between……she will also invite John Quigley or K. Washington from the CAP Cancer Committee to join in on the next call. | |||
##International templates: IHE should push the adoption of International models. | |||
[[File:Communique 1 final.pdf]] | |||
[[File:Communique 2 final.pdf]] | |||
[[File:D1Summary of CR survey.pdf]] | |||
[[File:D3Information_Note_7_Numbering_of_Linearizations_v.1.7.v1.docx]] | |||
[[File:D4ICD11-Status on 30 04 2012.docx]] | |||
[[File:D5ICD Neoplasms TAG F2F Minutes Lyon 201202FINAL(20120404).pdf]] | |||
[[File:D6TCMinutes22062012b.docx]] | |||
[[File:HistoricalOutline.docx]] | |||
[[File:IPALM SIG Presentation October 2012 Stockholm.pdf]] | |||
Latest revision as of 11:38, 16 November 2012
DRAFT
Attending
Mary Kennedy mkenned@cap.org; Hugh Glover hugh_glover@bluewaveinformatics.co.uk ; Raj Dash r.dash@duke.edu ; Francois Macary francois.macary@gmail.com ; Harry Solomon harry.solomon@ge.com ; Alessandro Sulis asulis@crs4.it ; Dave Toomey david.toomey@leica-microsystems.com ; John Murphy john.murphy@mtuitive.com
MINUTES
- Agenda Review
- IHE AP Report
- The report will be sent to Chris to put on domain once it is completed.
- Vendors have not implemented yet in France….. very few vendors in the French market for anatomic pathology
- There are some in Spain.
- French vendors will have to implement. APFR will be required.
- There is a national project of care coordination around cancer cases which is driven by ___ organization and the National Cancer institute in France.
- Presently working on the Tumor Board Report.
- Implementation should begin in 2013.
- …………..is working to update the implementation guide with 10 additional ……………so that the guide follows the medical specification of National ……………Institute.
- Status of IHE–IPALM Joint Initiative (Encoding Breast Cancer APSR)
- The feedback from the face-to-face meeting in Stockholm is scheduled to occur this Friday, November 16, 2012 at 8:00AM in the teleconference for ICD11.
- Comments on staging will be discussed.
- Raj will be able to provide feedback after this Friday.
- Email questions and concerns to Raj and he will share will submit for group discussion on Friday.
- A concern about the rational of not taking all the details of the T&M was voiced. Is it mainly for intellectual property issues or for simplification?
- There is opportunity in a single code to capture some epidemiologic data. It would be very difficult to capture all the T&M details in a single code with the code space that is available to ICD11. It is possible with the second code to provide more granular information.
- Mary will post to IHE AP site all the documents sent by Raj summarizing where ICD11 is going.
- A question was posed about whether there is a terms of reference document for ICD11. What is considered within the scope of what they are trying to do in ICD11?
- Raj will get the document and share. He will also find out if IHE can have access to draft of ICD11 to provide comments.
- IPALM next step: submit questions to INI Chair.
- Mary will put together questions for INI and post IPALM presentation on IHE.
- ''''Status of ICCR
- Will work on nephrology/urology/pathology
- Have contact with Spain, Italy, France, Switzerland, and New Zealand
- Have connection with….UICC
- It is not clear how IHE can be involved.
- There is no discussion regarding any kind of technology implementation of this at this point – IHE may bring to group.
- Mary will find out more information - regarding discrepancy between……she will also invite John Quigley or K. Washington from the CAP Cancer Committee to join in on the next call.
- International templates: IHE should push the adoption of International models.
File:D1Summary of CR survey.pdf
File:D3Information Note 7 Numbering of Linearizations v.1.7.v1.docx
File:D4ICD11-Status on 30 04 2012.docx
File:D5ICD Neoplasms TAG F2F Minutes Lyon 201202FINAL(20120404).pdf